#remdesivir

Anybody out there who watched their loved ones die in the hospital on forced #Remdesivir infusions...

Want to defend Marjorie Taylor Greene @mtgreenee to me now that you know she owns stock in the company that made the drug that killed your loved one?

How will she impartially investigate companies in which she has a direct financial interest?

View and subscribe to my work on GMO's, the Bioweapons, & The Great Reset at Rumble.com/c/drjaneruby

Oh L👀K! Among @mtgreenee numerous pharmaceutical stock holdings, particularly the companies that made billions killing American civilians and soldiers with the C 19 Bioweapon shots, she actually OWNS CRSPR GENE EDITING stock!!

Yes, the technology that enables transfection of the synthetic toxic gene codes into your human genome! Think she doesn't have a conflict of interest??

The first medicine seen to be effective against COVID-19 will no longer be free, beginning in as little as one week. The Remdesivir treatment, developed by drugmaker Gilead but sponsored largely by taxpayer-funded agencies, is shown to quicken recovery times for severely ill COVID-19 patients by up to 4 days. Remdesivir remains the only therapy authorized by the FDA to treat hospitalized COVID-19 patients. Gilead will begin charging those with private insurance $3,120 per treatment plan, and those with government health programs $2,340 per plan. The out-of-pocket amount will vary based on insurance, income, and other factors. The drugmaker says that cutting 4 days of hospital costs saves approx $12,000 per patient. Remdesivir has not been shown to make a significant difference in the survival rate.

Spread the word around.